Nova Mentis Life Stock Performance

NMLSF Stock  USD 0.03  0  6.14%   
Nova Mentis holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.72, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nova Mentis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Nova Mentis is expected to be smaller as well. Use Nova Mentis Life potential upside and the relationship between the skewness and relative strength index , to analyze future returns on Nova Mentis Life.

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nova Mentis Life are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Nova Mentis reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow2.1 M
  

Nova Mentis Relative Risk vs. Return Landscape

If you would invest  3.65  in Nova Mentis Life on September 1, 2024 and sell it today you would lose (1.05) from holding Nova Mentis Life or give up 28.77% of portfolio value over 90 days. Nova Mentis Life is currently producing 3.1274% returns and takes up 27.0116% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Nova, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Nova Mentis is expected to generate 36.01 times more return on investment than the market. However, the company is 36.01 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.2 per unit of risk.

Nova Mentis Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Mentis' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nova Mentis Life, and traders can use it to determine the average amount a Nova Mentis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1158

Best PortfolioBest Equity
Good ReturnsNMLSF
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 27.01
  actual daily
96
96% of assets are less volatile

Expected Return

 3.13
  actual daily
62
62% of assets have lower returns

Risk-Adjusted Return

 0.12
  actual daily
9
91% of assets perform better
Based on monthly moving average Nova Mentis is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nova Mentis by adding it to a well-diversified portfolio.

Nova Mentis Fundamentals Growth

Nova Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nova Mentis, and Nova Mentis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nova Pink Sheet performance.

About Nova Mentis Performance

By analyzing Nova Mentis' fundamental ratios, stakeholders can gain valuable insights into Nova Mentis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nova Mentis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nova Mentis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. Nova Mentis is traded on OTC Exchange in the United States.

Things to note about Nova Mentis Life performance evaluation

Checking the ongoing alerts about Nova Mentis for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nova Mentis Life help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Nova Mentis Life is way too risky over 90 days horizon
Nova Mentis Life has some characteristics of a very speculative penny stock
Nova Mentis Life appears to be risky and price may revert if volatility continues
Nova Mentis Life has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (2.68 M) with loss before overhead, payroll, taxes, and interest of (5.44 K).
Nova Mentis Life has accumulated about 634.36 K in cash with (1.95 M) of positive cash flow from operations.
Evaluating Nova Mentis' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Nova Mentis' pink sheet performance include:
  • Analyzing Nova Mentis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nova Mentis' stock is overvalued or undervalued compared to its peers.
  • Examining Nova Mentis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Nova Mentis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nova Mentis' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Nova Mentis' pink sheet. These opinions can provide insight into Nova Mentis' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Nova Mentis' pink sheet performance is not an exact science, and many factors can impact Nova Mentis' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Nova Pink Sheet analysis

When running Nova Mentis' price analysis, check to measure Nova Mentis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Mentis is operating at the current time. Most of Nova Mentis' value examination focuses on studying past and present price action to predict the probability of Nova Mentis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Mentis' price. Additionally, you may evaluate how the addition of Nova Mentis to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories